Exhibit 107
Calculation of Filing Fee Tables
Form S-3
(Form Type)
Kura Oncology, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
Security Type | Security Class Title | Fee Calculation or Carry Forward Rule | Amount Registered | Proposed Maximum Offering Price Per Share | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee | Carry Forward Form Type | Carry Forward File Number | Carry Forward Initial effective date | Filing Fee Previously Paid In Connection with Unsold Securities to be Carried Forward | |||||||||||||
Newly Registered Securities | ||||||||||||||||||||||||
Fees to Be Paid | Equity | Common Stock, par value $0.0001 per share | 457(o) and 457(r) | — | — | $150,000,000 | $92.70 | $13,905 | ||||||||||||||||
Fees Previously Paid | — | — | — | — | — | — | — | |||||||||||||||||
Carry Forward Securities | ||||||||||||||||||||||||
Carry Forward Securities | — | — | — | — | — | — | — | — | — | |||||||||||||||
Total Offering Amounts | $150,000,000 | $13,905 | ||||||||||||||||||||||
Total Fees Previously Paid | — | |||||||||||||||||||||||
Total Fee Offsets | — | |||||||||||||||||||||||
Net Fees Due | $13,905 |
Table 2: Fee Offset Claims and Sources
Registrant or Filer Name | Form or Filing Type | File Number | Initial Filing Date | Filing Date | Fee Offset Claimed | Security Type Associated with Fee Offset Claimed | Security Title Associated with Fee Offset Claimed | Unsold Securities Associated with Fee Offset Claimed | Unsold Aggregated Offering Amount Associated with Fee Offset Claimed | Fee Paid with Fee Offset Source | ||||||||||||
Rules 457(b) and 0-11(a)(2) | ||||||||||||||||||||||
Fee Offset Claims | — | — | — | — | ||||||||||||||||||
Fee Offset Sources | — | — | — | — | — | |||||||||||||||||
Rule 457(p)(1) | ||||||||||||||||||||||
Fee Offset Claims | Kura Oncology, Inc. | S-3 | 333-228172 | 11/5/2018 | $10,260 | Unallocated (Universal) Shelf | Common Stock, par value $0.0001 per share | — | $84,650,000 | |||||||||||||
Fee Offset Sources | Kura Oncology, Inc. | S-3 | 333-228172 | 11/5/2018 | 11/5/2018 | $10,260 |
(1) | The registrant’s registration statement on Form S-3 (File No. 333-228172), filed with the Securities and Exchange Commission on November 5, 2018 and declared effective on November 11, 2018, expired on November 11, 2021. |